Prestige Consumer Healthcare (PBH)

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
Prestige Consumer Healthcare Inc	-43.3	0%	-5%	3.2	0.8
Market Avg	54.3	1.27%	32%	-	1.3
Healthcare Avg	39.1	1.36%	17%	7.2	1.3

November 6, 2022 - AI Summary

Q2 revenues of $289 million, up 5% organically compared to the prior year.

Strong sales performance driven by the International segment and the Hydralyte brand.

E-commerce business grew 15% in the first half of the year, outpacing other non-healthcare categories.

$185.04

162.9% upside

Undervalued by 162.9% based on the discounted cash flow analysis.

P/E Ratio	-43.28
PEG	-2053.31
Price to Sales	3.2
Price to Book Ratio	2.2
Enterprise Value to Revenue	4.08
Enterprise Value to EBIT	13.25
Enterprise Value to Net Income	-58
Total Debt to Enterprise	0.26
Debt to Equity	0.75

Prestige Consumer Healthcare Inc